2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide

C146H195N13O7S3 — CID 159791498

IUPAC2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide
SMILESCC(C)c1ccc(CNCCc2c[nH]c3ccccc23)cc1.CC(C)c1ccc(CNCCc2cn(C)c3ccccc23)cc1.CC(C)c1cccc(S(=O)(=O)N(C)CCc2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)N(C)c2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)NCCc2ccccc2)c1.CC(C)c1ccccc1.CCCCc1nc2cc(C(C)C)ccc2n1CCN(C)C.CCCCc1nc2cc(C(C)C)ccc2n1CCNC.COc1ccc(C(C)C)cc1
InChIInChI=1S/C21H26N2.C20H24N2.C18H29N3.C18H23NO2S.C17H27N3.C17H21NO2S.C16H19NO2S.C10H14O.C9H12/c1-16(2)18-10-8-17(9-11-18)14-22-13-12-19-15-23(3)21-7-5-4-6-20(19)21;1-15(2)17-9-7-16(8-10-17)13-21-12-11-18-14-22-20-6-4-3-5-19(18)20;1-6-7-8-18-19-16-13-15(14(2)3)9-10-17(16)21(18)12-11-20(4)5;1-15(2)17-10-7-11-18(14-17)22(20,21)19(3)13-12-16-8-5-4-6-9-16;1-5-6-7-17-19-15-12-14(13(2)3)8-9-16(15)20(17)11-10-18-4;1-14(2)16-9-6-10-17(13-16)21(19,20)18-12-11-15-7-4-3-5-8-15;1-13(2)14-8-7-11-16(12-14)20(18,19)17(3)15-9-5-4-6-10-15;1-8(2)9-4-6-10(11-3)7-5-9;1-8(2)9-6-4-3-5-7-9/h4-11,15-16,22H,12-14H2,1-3H3;3-10,14-15,21-22H,11-13H2,1-2H3;9-10,13-14H,6-8,11-12H2,1-5H3;4-11,14-15H,12-13H2,1-3H3;8-9,12-13,18H,5-7,10-11H2,1-4H3;3-10,13-14,18H,11-12H2,1-2H3;4-13H,1-3H3;4-8H,1-3H3;3-8H,1-2H3
InChIKeyNIPPXCZOZGFNKH-UHFFFAOYSA-N
MW2340.45 g/mol
LogP33.31
Rot. Bonds45

About 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide

2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide (PubChem CID 159791498) has the molecular formula C146H195N13O7S3 and a molecular weight of 2340.45 g/mol. Its IUPAC name is 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide.

Molecular Properties

Compound Name2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide
PubChem CID159791498
Molecular FormulaC146H195N13O7S3
Molecular Weight2340.45 g/mol
Exact Mass2338.45
IUPAC Name2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide
SMILESCC(C)c1ccc(CNCCc2c[nH]c3ccccc23)cc1.CC(C)c1ccc(CNCCc2cn(C)c3ccccc23)cc1.CC(C)c1cccc(S(=O)(=O)N(C)CCc2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)N(C)c2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)NCCc2ccccc2)c1.CC(C)c1ccccc1.CCCCc1nc2cc(C(C)C)ccc2n1CCN(C)C.CCCCc1nc2cc(C(C)C)ccc2n1CCNC.COc1ccc(C(C)C)cc1
InChIInChI=1S/C21H26N2.C20H24N2.C18H29N3.C18H23NO2S.C17H27N3.C17H21NO2S.C16H19NO2S.C10H14O.C9H12/c1-16(2)18-10-8-17(9-11-18)14-22-13-12-19-15-23(3)21-7-5-4-6-20(19)21;1-15(2)17-9-7-16(8-10-17)13-21-12-11-18-14-22-20-6-4-3-5-19(18)20;1-6-7-8-18-19-16-13-15(14(2)3)9-10-17(16)21(18)12-11-20(4)5;1-15(2)17-10-7-11-18(14-17)22(20,21)19(3)13-12-16-8-5-4-6-9-16;1-5-6-7-17-19-15-12-14(13(2)3)8-9-16(15)20(17)11-10-18-4;1-14(2)16-9-6-10-17(13-16)21(19,20)18-12-11-15-7-4-3-5-8-15;1-13(2)14-8-7-11-16(12-14)20(18,19)17(3)15-9-5-4-6-10-15;1-8(2)9-4-6-10(11-3)7-5-9;1-8(2)9-6-4-3-5-7-9/h4-11,15-16,22H,12-14H2,1-3H3;3-10,14-15,21-22H,11-13H2,1-2H3;9-10,13-14H,6-8,11-12H2,1-5H3;4-11,14-15H,12-13H2,1-3H3;8-9,12-13,18H,5-7,10-11H2,1-4H3;3-10,13-14,18H,11-12H2,1-2H3;4-13H,1-3H3;4-8H,1-3H3;3-8H,1-2H3
InChIKeyNIPPXCZOZGFNKH-UHFFFAOYSA-N
XLogP33.31
TPSA225.85 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds45
Heavy Atoms169
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002340.45
LogP ≤ 533.31
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[1-[3,5-difluoro-4-[4-(4-methoxyphenyl)piperidin-1-yl]phenyl]-2-[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrol-3-yl]-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole
CID 68279017
9-[2-[3-[[4-[[3-[2-[3,6-bis(4-methoxy-N-(4-methoxyphenyl)anilino)carbazol-9-yl]ethyl]imidazol-3-ium-1-yl]methyl]phenyl]methyl]imidazol-1-ium-1-yl]ethyl]-3-N,6-N,6-N-tris(4-methoxyphenyl)-3-N-(4-methylphenyl)carbazole-3,6-diamine;methane;bis(1,1,1-trifluoro-N-methylsulfonylmethanesulfonamide)
CID 158969340
3-N,6-N-bis(4-ethenylphenyl)-9-[4-[(3-ethylimidazol-3-ium-1-yl)methyl]phenyl]-3-N,6-N-bis(4-methoxyphenyl)carbazole-3,6-diamine;bis(bis(trifluoromethylsulfonyl)azanide);9-[[4-[[3-[(4-ethenylphenyl)methyl]imidazol-3-ium-1-yl]methyl]phenyl]methyl]-3-N,3-N,6-N,6-N-tetrakis(4-methoxyphenyl)carbazole-3,6-diamine
CID 159282306
N-methyl-2-[2-[(E)-2-[3-(trifluoromethoxy)phenyl]ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide;N-methyl-2-[2-[(E)-2-[4-(trifluoromethoxy)phenyl]ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide;N-methyl-2-[2-[(E)-2-[2-(trifluoromethyl)phenyl]ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide
CID 159341921
2-[2-[2-(4-methoxyphenyl)ethyl]-3H-benzimidazol-5-yl]benzenesulfonamide;2-[2-[(E)-2-[4-(trifluoromethylsulfonylamino)phenyl]ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide;1,1,1-trifluoro-N-[4-[(E)-2-[6-[2-(trifluoromethylsulfonylamino)phenyl]-1H-benzimidazol-2-yl]ethenyl]phenyl]methanesulfonamide
CID 160010372
1,1,1-trifluoro-N-[2-[2-[2-(4-methoxyphenyl)ethyl]-3H-benzimidazol-5-yl]phenyl]methanesulfonamide;1,1,1-trifluoro-N-[2-[2-[2-[4-(trifluoromethyl)phenyl]ethyl]-3H-benzimidazol-5-yl]phenyl]methanesulfonamide;1,1,1-trifluoro-N-[2-[2-[2-[4-(trifluoromethylsulfonyl)phenyl]ethyl]-3H-benzimidazol-5-yl]phenyl]methanesulfonamide
CID 160225310
2-[2-[2-[4-(trifluoromethoxy)phenyl]cyclopropyl]-3H-benzimidazol-5-yl]benzenesulfonamide;2-[2-[2-[4-(trifluoromethylsulfonylamino)phenyl]ethyl]-3H-benzimidazol-5-yl]benzenesulfonamide;1,1,1-trifluoro-N-[4-[2-[6-[2-(trifluoromethylsulfonylamino)phenyl]-1H-benzimidazol-2-yl]ethyl]phenyl]methanesulfonamide
CID 160784489
3-N,6-N-bis(4-ethenylphenyl)-9-[4-[(3-ethylimidazol-3-ium-1-yl)methyl]phenyl]-3-N,6-N-bis(4-methoxyphenyl)carbazole-3,6-diamine;9-[[4-[[3-[(4-ethenylphenyl)methyl]imidazol-3-ium-1-yl]methyl]phenyl]methyl]-3-N,3-N,6-N,6-N-tetrakis(4-methoxyphenyl)carbazole-3,6-diamine;methane;bis(1,1,1-trifluoro-N-methylsulfonylmethanesulfonamide)
CID 160799742
2-[2-[(E)-2-(4-ethoxyphenyl)ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide;4-fluoro-2-[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-3H-benzimidazol-5-yl]benzenesulfonamide;2-[2-[2-(4-propan-2-ylphenyl)ethyl]-3H-benzimidazol-5-yl]benzenesulfonamide
CID 161737461
2-[(2S)-2-[6-[(2R,5R)-1-[3,5-difluoro-4-[4-(4-methoxyphenyl)cyclohexyl]phenyl]-5-[2-[(2S)-1-[(3S)-3,4-dimethylpent-1-en-2-yl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-1H-indol-2-yl]pyrrolidin-1-yl]prop-2-en-1-amine
CID 144433467
1-[(4-Methoxyphenyl)methyl]-3-[2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]phenyl]sulfonylurea
CID 15295809
2-(4-Methoxyphenyl)-5-methyl-1-[[1-(4-methylphenyl)sulfonylindol-3-yl]methyl]benzimidazole
CID 68515839

Frequently Asked Questions

What is the IUPAC name of 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide?
The IUPAC name of 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide (CID 159791498) is 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide.
What is the SMILES notation for 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide?
The canonical SMILES for 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide is CC(C)c1ccc(CNCCc2c[nH]c3ccccc23)cc1.CC(C)c1ccc(CNCCc2cn(C)c3ccccc23)cc1.CC(C)c1cccc(S(=O)(=O)N(C)CCc2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)N(C)c2ccccc2)c1.CC(C)c1cccc(S(=O)(=O)NCCc2ccccc2)c1.CC(C)c1ccccc1.CCCCc1nc2cc(C(C)C)ccc2n1CCN(C)C.CCCCc1nc2cc(C(C)C)ccc2n1CCNC.COc1ccc(C(C)C)cc1.
What is the InChIKey of 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide?
The InChIKey is NIPPXCZOZGFNKH-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H26N2.C20H24N2.C18H29N3.C18H23NO2S.C17H27N3.C17H21NO2S.C16H19NO2S.C10H14O.C9H12/c1-16(2)18-10-8-17(9-11-18)14-22-13-12-19-15-23(3)21-7-5-4-6-20(19)21;1-15(2)17-9-7-16(8-10-17)13-21-12-11-18-14-22-20-6-4-3-5-19(18)20;1-6-7-8-18-19-16-13-15(14(2)3)9-10-17(16)21(18)12-11-20(4)5;1-15(2)17-10-7-11-18(14-17)22(20,21)19(3)13-12-16-8-5-4-6-9-16;1-5-6-7-17-19-15-12-14(13(2)3)8-9-16(15)20(17)11-10-18-4;1-14(2)16-9-6-10-17(13-16)21(19,20)18-12-11-15-7-4-3-5-8-15;1-13(2)14-8-7-11-16(12-14)20(18,19)17(3)15-9-5-4-6-10-15;1-8(2)9-4-6-10(11-3)7-5-9;1-8(2)9-6-4-3-5-7-9/h4-11,15-16,22H,12-14H2,1-3H3;3-10,14-15,21-22H,11-13H2,1-2H3;9-10,13-14H,6-8,11-12H2,1-5H3;4-11,14-15H,12-13H2,1-3H3;8-9,12-13,18H,5-7,10-11H2,1-4H3;3-10,13-14,18H,11-12H2,1-2H3;4-13H,1-3H3;4-8H,1-3H3;3-8H,1-2H3.
What are the key properties of 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide?
2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide has a molecular weight of 2340.45 g/mol, XLogP of 33.31, 45 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N,N-dimethylethanamine;2-(2-butyl-5-propan-2-ylbenzimidazol-1-yl)-N-methylethanamine;cumene;2-(1H-indol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;1-methoxy-4-propan-2-ylbenzene;2-(1-methylindol-3-yl)-N-[(4-propan-2-ylphenyl)methyl]ethanamine;N-methyl-N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide;N-methyl-N-phenyl-3-propan-2-ylbenzenesulfonamide;N-(2-phenylethyl)-3-propan-2-ylbenzenesulfonamide is sourced from PubChem (CID 159791498), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).